PI Industries
PI Industries faces severe headwinds in its core AgChem export business, masking strong domestic and biological growth.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every PI Industries earnings call we streamed: the live audio and our summary of what management said.
PI Industries faces severe headwinds in its core AgChem export business, masking strong domestic and biological growth.
PI Industries faces severe headwinds in its core AgChem export business, masking strong domestic and biological growth.
Management expects a 'flattish' FY27 revenue, targeting $100 million in specialty electronics revenue within 3-4 years.
PI Industries Q1 FY27 results show resilience amidst global agrochemical headwinds, maintaining healthy EBITDA margins at 22% despite revenue softness. Management remains optimistic about a second-half recovery driven by domestic monsoon improvement and new product scale-ups.
PI Industries delivered FY26 revenue of ₹67,137M with 25% EBITDA margins. Management transitioned to an innovator-led model with the launch of its first homegrown NCE, Pioxaniliprole.
PI Industries delivered a resilient FY26 despite a global agrochemical downcycle. Management is pivoting toward life sciences and electronic chemicals to de-risk from their single-molecule dependency and agrochemical volatility.
PI Industries reported FY26 revenue of ₹67,137 Mn, down 16% YoY, and PAT of ₹13,208 Mn, down 20%, amid a global agrochemical downcycle.
PI Industries reported a challenging Q4FY26 with revenue and PAT down 12% and 39% respectively due to global agrochemical contraction, while maintaining healthy 58% gross margins.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.